Total Funding: 230600000.0
Headquarters: Cambridge, Massachusetts, United States
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Series B
Technology: Biopharma, Biotechnology, Life Science
Last Funding Date: 2021-11-09
Investors Number: 21.0
Founded Date: 2016-01-01
Industry: Early Drug Development